PharmaBoardroom

New CEO for Ipsen as David Loew Makes Switch From Sanofi Pasteur

David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi's vaccines division, was appointed CEO of fellow French firm Ipsen on the 28th…

Geert Van Hoof – General Manager, Chiesi Belgium

Geert Van Hoof, founding general manager of Chiesi Belgium, shares the exciting milestones of the company’s first decade in Belgium, including their…

European Pharma Mid-Caps’ US Strategies: Complexity, Scale,…

Three US country managers for European pharma mid-caps explain the challenges in setting up an American affiliate, as well as how best to capitalise…

Constanza Losada – President & CEO, Pfizer Mexico

Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking on leadership for such an…

France & Germany: A New European Approach to Health Crises

Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would ensure greater European access to…

Jose Antonio Moreno Toscano – CEO, LFB USA

Jose Antonio Moreno Toscano, CEO for the US affiliate of iconic French firm LFB shares the company’s journey in the US market and his insights for…

Luis Calderon – General Manager, Biogen Mexico

Biogen Mexico’s Luis Calderon discusses establishing the affiliate, the opportunities apparent in the Mexican neurodegenerative disease market, and…

Ronald Boueri – General Manager, Zimmer Biomet Middle East

Ronald Boueri of Zimmer Biomet Middle East discusses the challenges of establishing the business, the importance of providing the latest innovation…

Joan Shen – CEO, I-Mab Biopharma

Dr Joan Shen, CEO of I-Mab Biopharma, shares her impressive career journey across companies like Pfizer, Janssen and Jiangsu Hengrui, before joining…

Desmond Hau – CEO, Pangenia Group

Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago.…

Pharma Faces: Jorge Alderete, ALK Americas

Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in…

Jorge Alderete – President, ALK Americas & SVP…

Jorge Alderete, president of ALK Americas, outlines the Danish mid-cap’s strategy in the challenging US market, including innovative market access…

Tagged with strategy